|Bid||0.4301 x 3000|
|Ask||0.4401 x 800|
|Day's Range||0.4300 - 0.4450|
|52 Week Range||0.3000 - 1.2800|
|Beta (5Y Monthly)||0.25|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 08, 2023 - Feb 13, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.75|
The Zacks Medical - Instruments industry is growing on rising demand for digital health. SWAV, MLAB and DYNT are set to gain the most. Yet, the ongoing inflation in the form of rising freight, raw material and labor costs is an overhang.
Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of 33.33% and 2.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
/ Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its first quarter of fiscal year 2023 ended September 30, 2022, and provided an update on recent business highlights.